BCAT-IN-4 - An Overview
The key finish position was the security and tolerability of sifalimumab. Therapy-emergent adverse occasions (AEs) and really serious AEs (SAEs) as well as their severity, outcome, and any romance to the research medication ended up recorded by the investigator all over the study. AEs ended up considered likely to be connected with review medicatio